日本口服避孕药使用者血栓风险评估:一项目标试验模拟研究
Risk of thrombosis associated with oral contraceptive pills use in Japan: a target trial emulation study
研究团队使用日本行政数据库评估了口服避孕药使用者的血栓风险,发现不同雌激素剂量的口服避孕药与血栓风险存在剂量依赖关系,特别是含有drospirenone的口服避孕药风险更高。
研究团队通过真实世界数据评估了口服避孕药与血栓风险的关系,为临床用药提供参考。
- Article
- Open access
- Published: 12 November 2026
- Saki Takeshita1,
- Yuichi Nishioka1,2,
- Emiri Morita1,
- Tomoya Myojin1,3,
- Tatsuya Noda4,
- Takashi Sugiyama5 &
- …
- Tomoaki Imamura1
Scientific Reports (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
The thrombosis risk associated with the latest oral contraceptive pills (OCPs) is unclear. Additionally, few studies have assessed thrombosis risk in Asian OCP users, despite wide variations in thrombosis incidence across ethnic groups. We emulated a target trial using DeSC database, an administrative claims database including monthly claims from medical institutions and pharmacies, health checkups data, and registry information in Japan from April 2014 to January 2023. Women who met both the inclusion and exclusion criteria and were not classified as OCP users served as controls. The participants were followed for one year. 59 thrombotic events (OCP group: 40; control: 19) occurred during the follow-up. The rate ratio (RR) of thrombosis among OCP users compared with control was 2.1 (95% confidence interval, 1.5–2.8). The RR among women using OCPs with 50 μg of ethinyl estradiol (EE) was 2.4 (1.5–3.3), and that among those using OCPs with EE < 50 μg was 1.8 (0.8–2.7). For users of 20 μg of EE, the RR was 1.0 (0–2.0) for norethisterone and 2.3 (0.6–4.1) for drospirenone in the three-year extended follow-up period. Our findings suggest a dose-dependent association between estrogen dose in OCPs and thrombosis onset, with a potentially higher risk for OCPs containing drospirenone in Japan. The thrombosis risk was generally higher among OCP users, both in the one-year and the three-year analyses.
Similar content being viewed by others



Abbreviations
- OCPs:
-
Oral contraceptive pills
Funding
This study was supported by the Japan Society for the Promotion of Science KAKENHI (Grant Numbers: 22H03355, 23K24613, 23H00507 and 24K22341), and the Health and Labor Science Research Grants (HLSRG) (Grant Number: 24IA1009).
Author information
Authors and Affiliations
Department of Public Health, Health Management and Policy, Nara Medical University, Kashihara, Nara, Japan
Saki Takeshita, Yuichi Nishioka, Emiri Morita, Tomoya Myojin & Tomoaki Imamura
Department of Diabetes and Endocrinology, Nara Medical University, Kashihara, Nara, Japan
Yuichi Nishioka
Department of Community Health and Preventive Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan
Tomoya Myojin
Department of Public Health Informatics, Kansai Medical University, Hirakata, Osaka, Japan
Tatsuya Noda
Department of Obstetrics and Gynecology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan
Takashi Sugiyama
Authors
- Saki Takeshita
- Yuichi Nishioka
- Emiri Morita
- Tomoya Myojin
- Tatsuya Noda
- Takashi Sugiyama
- Tomoaki Imamura
Corresponding authors
Correspondence to Saki Takeshita or Yuichi Nishioka.
Ethics declarations
Competing interests
Y.N. received consultation fees from Novo Nordisk, and speaker fees from Sanofi, Daiichi Sankyo, and DeSC Healthcare.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Takeshita, S., Nishioka, Y., Morita, E. et al. Risk of thrombosis associated with oral contraceptive pills use in Japan: a target trial emulation study. Sci Rep (2026). https://doi.org/10.1038/s41598-026-74972-9
Received: 10 May 2026
Accepted: 05 October 2026
Published: 12 November 2026
DOI: https://doi.org/10.1038/s41598-026-74972-9
Keywords
来源:Nature 健康护理主题 · nature.com